Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
about
Calcium antagonists for aneurysmal subarachnoid haemorrhageCurrent controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleedingCurrent options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literatureTreatment of intracranial vasospasm following subarachnoid hemorrhage.Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials.Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysmLower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage.Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.Magnesium: potential roles in neurovascular diseaseThe changes of von willebrand factor/a disintegrin-like and metalloprotease with thrombospondin type I repeats-13 balance in aneurysmal subarachnoid hemorrhagePharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.Modern Approach to SAH in Intensive Care Unit (ICU).Neuroprotection in subarachnoid hemorrhageMagnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trialAchieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhageMagnesium sulfate treatment improves outcome in patients with subarachnoid hemorrhage: a meta-analysis study.Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhageMagnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.Considerations in fluids and electrolytes after traumatic brain injury.Recent advances in neuroprotection for treating traumatic brain injury.Endovascular management of intracranial aneurysms: current experience and future advances.Magnesium treatment for neuroprotection in ischemic diseases of the brain.Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions.Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?A review of medical treatments of cerebral vasospasm.Medical management of cerebral vasospasm: present and future.Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm: a single center experience.Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives.Is there a future for neuroprotective agents in cardiac surgery?Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.Current and future treatment considerations in the management of aneurysmal subarachnoid hemorrhage.Magnesium sulfate administration in subarachnoid hemorrhage.Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.
P2860
Q24244167-5FC5ECBB-1C39-432A-9E00-6CBF797B4FA1Q26823280-CA554C04-F084-4413-8FCF-251D777883C9Q31152215-0BEA345A-D249-4A4A-8F41-F97543CCE4E3Q33545385-7CBDA967-8BE7-4A9D-AF73-01D16D27E1F3Q33626060-D45E142F-649F-4054-BE51-C1F7F51F086CQ33653064-AA696BFA-12E3-4A7C-9B74-C1AC7561165FQ33658415-BD49C179-66B6-4837-A1F5-3F28CF8B6F87Q34068557-87A9D075-5724-4A6D-9DBF-4C838171E178Q34233894-E66B42D3-1124-4B35-9899-10B5E24DB35BQ34612924-9197B28F-0CAB-4238-8673-B7ADE4CC2412Q34977035-8A24E242-ADDA-4D86-8B79-8AF919C23725Q35108572-E78D9CD0-0128-4A74-BC44-C30EB8538EE8Q35118170-880CC330-0E34-45E6-A914-EAAA7CA00C0CQ35159997-155A69AA-91A2-4BF4-B523-5B705FFBE9B6Q35173887-5DEB5CA2-75B6-4E0D-A53B-61776C8D3B3DQ35574105-5BCC787D-B41C-43A7-85A5-D5A188A7471DQ35780403-A3D96625-6CDC-47B0-A860-16AB37756435Q35893292-3A1C9B7A-6847-48B3-93EC-7E12996E4BDAQ36034824-98BF34FB-F1BF-4126-944F-6A485691997CQ36082058-133E7DBE-F49E-4C8B-9A61-90E5BAF50161Q36227040-31478AEF-B276-4515-BE71-8E6E59939383Q36251564-C70603D6-513A-4ED6-BEF1-F01CE811E575Q36392740-C7694BB3-2D16-4930-9BDD-3A94D65E1FE7Q36499342-1A2EA94C-7564-4F72-9EB1-59EAEDA70B36Q36602392-D6B26D91-39C4-40F3-9E12-4E4664DE805FQ36623065-8A107C2D-2B0E-4C0D-A83F-BB223FE32A4DQ36629812-1C02C244-9F64-4551-9307-1D2E4FC3BDD2Q36811695-45AD87E5-06BA-4A72-96F0-2360D90119A7Q36831190-03ED38D0-549D-448E-9222-1FA2173B0703Q36937589-55817F4D-D217-4581-B9CD-6983C9677513Q37309288-7A40CAD9-50BB-4110-B231-954E66106894Q37340982-EBFC91C7-2912-4B56-93A8-42B72F24C3E6Q37574227-F42FC8E4-2A09-438C-9C9B-3BA95E3EF936Q37620987-1AAB525F-0292-4EB6-B039-7A6CAA911F20Q37755882-5BCC56D4-2A4E-48D4-9C9D-18232D68AC98Q37767423-73744D0F-5C89-43E1-A735-826509C8A024Q37837083-02A30116-DCDB-4D31-ADAC-051632DF1021Q37867298-E099C494-AD03-4A82-83FA-D88DD1EF8F90Q37900209-A07A9CAF-BDDF-4C28-B960-E9F5EBE65707Q37902985-0F5A4B2A-D5D0-424C-8CD6-3F97A9D9CBC7
P2860
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@en
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@nl
type
label
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@en
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@nl
prefLabel
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@en
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@nl
P2093
P1433
P1476
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
@en
P2093
C M F Dirven
F van Kooten
G J E Rinkel
J van Gijn
M Vermeulen
MASH Study Group
Walter M van den Bergh
P304
P356
10.1161/01.STR.0000160801.96998.57
P407
P577
2005-03-24T00:00:00Z